Free fatty acid uptake in humans with CD36 deficiency

Diabetes

Volumn 63, Issue 11, 2014, Pages 3606-3614

  Hames, Kazanna C ^a   Vella, Adrian ^a   Kemp, Bradley J ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; FATTY ACID; PALMITIC ACID C 11; PROLINE; SERINE; LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FATTY ACID TRANSPORT; FEMALE; HEART MUSCLE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LIVER; MALE; MUTATION; ADOLESCENT; CARDIAC MUSCLE; DEFICIENCY; GENETICS; METABOLISM; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD36; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LEPTIN; LIVER; MALE; MIDDLE AGED; MUTATION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84908611783     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0369     Document Type: Article

References (43)

1. Goldberg IJ, Eckel RH, Abumrad NA. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J Lipid Res 2009;50 (Suppl.):S86-S90
2. Hajri T, Abumrad NA. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 2002;22:383-415
3. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999;274:19055-19062
4. Ibrahimi A, Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 2002;5:139-145
5. Harmon CM, Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 1993;133: 43-49
6. Bastie CC, Hajri T, Drover VA, Grimaldi PA, Abumrad NA. CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. Diabetes 2004;53:2209-2216
7. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000;275:32523-32529
8. Ibrahimi A, Bonen A, Blinn WD, et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 1999;274:26761-26766
9. Bessi VL, Labbé SM, Huynh DN, et al. EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice. Cardiovasc Res 2012;96:99-108
10. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992;80:1105-1115
11. Kashiwagi H, Tomiyama Y, Honda S, et al. Molecular basis of CD36 deficiency. Evidence that a 478C-.T substitution (proline90-.serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995;95:1040-1046
12. Kashiwagi H, Tomiyama Y, Nozaki S, et al. Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man. Hum Genet 2001;108:459-466
13. Iizuka Y, Gotoda T, Ishibashi S, Yamada N. CD36 deficiency and insulin resistance. Lancet 2001;358:243
14. Yanai H, Chiba H, Morimoto M, et al. Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet 2000;93: 299-304
15. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet 2001;357:686-687
16. Okamoto F, Tanaka T, Sohmiya K, Kawamura K. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy. Jpn Circ J 1998;62:499-504
17. Tanaka T, Nakata T, Oka T, et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 2001;42:751-759
18. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997;29:121-127
19. Shadid S, Koutsari C, Jensen MD. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes 2007;56:1369-1375
20. Kihlberg T, Valind S, Längström B. Synthesis of fatty acids specifically labelled with 11C in various positions, including 2H substitution, for in vivo studies of myocardium using PET. Nucl Med Biol 1994;21:1053-1065
21. Zielinski F, Robinson G Jr. Synthesis of high purity 11C labeled palmitic acid for measurement of regional myocardial perfusion and metabolism. Int J Nucl Med Biol 1984;11:121-128
22. Tchoukalova YD, Harteneck DA, Karwoski RA, Tarara J, Jensen MD. A quick, reliable, and automated method for fat cell sizing. J Lipid Res 2003;44: 1795-1801
23. Allred CC, Krennmayr T, Koutsari C, Zhou L, Ali AH, Jensen MD. A novel ELISA for measuring CD36 protein in human adipose tissue. J Lipid Res 2011;52: 408-415
24. Ali AH, Koutsari C, Mundi M, et al. Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes 2011;60: 2300-2307
25. Miles JM, Ellman MG, McClean KL, Jensen MD. Validation of a new method for determination of free fatty acid turnover. Am J Physiol 1987;252:E431-E438
26. Persson X-MT, Blachnio-Zabielska AU, Jensen MD. Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res 2010;51:2761-2765
27. Shadid S, Jensen MD. Pioglitazone increases non-esterified fatty acid clearance in upper body obesity. Diabetologia 2006;49:149-157
28. Fox KA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically. Circ Res 1985; 57:232-243
29. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37:1723-1730
30. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584-590
31. Koutsari C, Mundi MS, Ali AH, Jensen MD. Storage rates of circulating free fatty acid into adipose tissue during eating or walking in humans. Diabetes 2012; 61:329-338
32. Koutsari C, Ali AH, Mundi MS, Jensen MD. Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes 2011;60:2032-2040
33. Jensen MD, Hensrud D, O'Brien PC, Nielsen S. Collection and interpretation of plasma leptin concentration data in humans. Obes Res 1999;7:241-245
34. Fukuchi K, Nozaki S, Yoshizumi T, et al. Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J Nucl Med 1999;40:239-243
35. Kintaka T, Tanaka T, Imai M, Adachi I, Narabayashi I, Kitaura Y. CD36 genotype and long-chain fatty acid uptake in the heart. Circ J 2002;66:819-825
36. Hajri T, Hall AM, Jensen DR, et al. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 2007;56:1872-1880
37. Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab 2007; 292:E1740-E1749
38. Wisneski JA, Gertz EW, Neese RA, Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987; 79:359-366
39. Glatz JFC, Luiken JJFP, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 2010;90:367-417
40. Drover VA, Nguyen DV, Bastie CC, et al. CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice. J Biol Chem 2008;283:13108-13115
41. Koutsari C, Mundi MS, Ali AH, Patterson BW, Jensen MD. Systemic free fatty acid disposal into very low-density lipoprotein triglycerides. Diabetes 2013;62: 2386-2395
42. Goudriaan JR, Dahlmans VEH, Teusink B, et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res 2003;44:2270-2277
43. Furuhashi M, Ura N, Nakata T, Shimamoto K. Insulin sensitivity and lipid metabolism in human CD36 deficiency. Diabetes Care 2003;26:471-474